BCL2 and transitional cell carcinoma: To evaluate the mRNA expression ratio of Bcl-2/Bax both in normal and tumoralbladder tissues of patients with transitional cell carcinoma (TCC) of bladder andinvestigate potential correlation between this expression ratio and clinical outcome.